On Wednesday, burning rock biotech (BNR.US) rose nearly 14%, to $6.95.
According to the Wise Finance app, on Wednesday, burning rock biotech (BNR.US) rose nearly 14%, to $6.95. In the third quarter of 2024, burning rock biotech achieved revenue of 0.1287 billion RMB, a year-on-year increase of 1%. After deducting Non-GAAP gross profit, Non-GAAP sales, and general administrative and management expenses, the third quarter realized a profit of 25.2 million RMB. So far, burning rock biotech has achieved profits for three consecutive quarters and shows a continuous upward trend.